✦ LIBER ✦

Efficacy, quality of life, safety, and tolerability in patients with chronic hepatitis C treated with PEG (40 kDa) IFN α-2a (PEGASYS®) or standard interferon Alfa-2b/ribavirin (REBETRON™) combination therapy

✍ Scribed by Kenneth D. Rothstein; Robert P. Perrillo; Joanne Imperial; Imtiaz Alam; Melissa Palmer; Paul J. Pockros; Stephen C. Pappas; Bradley S. Doerschuk; Lucy Wynohradnyk

Book ID: 119429247
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 366 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(08)80382-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability in pa

Efficacy, safety, and tolerability in patients switched to PEG (40 kDa) IFN α-2a (PEGASYS®) after discontinuation from interferon alfa-2b plus ribavirin (REBETRON™) combination therapy for chronic hepatitis C

✍ Perrillo, Robert P.; Rothstein, Kenneth D.; Alam, Imtiaz; Thuluvath, Paul J.; Pa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB

1042 EFFICACY AND SAFETY RESULTS OF ALBI

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

✍ Nelson, D.; Benhamou, Y.; Chuang, W.L.; Lawitz, E.; Flisiak, R.; Rodriguez-Torre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Virological response and safety outcomes

Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study

✍ Robert G. Gish; Sanjeev Arora; K. Rajender Reddy; David R. Nelson; Christopher O 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Pegylated (40 kDa) interferon alfa-2a (P

Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with Ribavirin, mycophenolate motelil (CellCept®), amantadine, or amantadine plus ribavirin in patients that relapsed on rebetronTM therapy: A preliminary report of a randomized, multicenter efficacy and safety study

✍ Herrine, Steven K.; Brown, Robert; Esposito, Stephen; Lok, Anna; Galati, Joseph 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The efficacy of combined interferon-alfa

The efficacy of combined interferon-alfa-2B and ribavirin therapy in patients with chronic hepatitis C. Final reports of a multicenter study with 100 patients in Hungary

✍ J. Fehér; G. Lengyel; T. Bálint 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

M1794 Efficacy and Tolerability of Pegin

M1794 Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions

✍ Hueppe, Dietrich; Zehnter, Elmar; Mauss, Stefan; Kaiser, Stephan; Schober, Andre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB